Synthesis of iron-boride/carbon-nitride composites and their applications in chemodynamic therapyShow others and affiliations
2024 (English)In: Journal of Colloid and Interface Science, ISSN 0021-9797, E-ISSN 1095-7103, Vol. 658, p. 276-285Article in journal (Refereed) Published
Abstract [en]
Chemodynamic therapy (CDT) is an emerging treatment strategy that inhibits tumor growth by catalyzing the generation of reactive oxygen species (ROS), such as hydroxyl radicals (center dot OH), using specific nanomaterials. Herein, we have developed a new class of iron-based nanomaterials, i.e., iron-based borides (FeB), using the superchaotropic effect of a boron cluster (closo-[B12H1212-) and organic ligands, followed by high-temperature calcination. Experimental data and theoretical calculations revealed that FeB nanoparticles exhibit a Fentonlike effect, efficiently decomposing hydrogen peroxide into center dot OH and thus increasing the concentration of ROS. FeB nanomaterials demonstrate excellent catalytic performance, efficiently generate ROS, and exert significant antitumor effects in cell experiments and animal models. Therefore, FeB nanomaterials have
Place, publisher, year, edition, pages
ACADEMIC PRESS INC ELSEVIER SCIENCE , 2024. Vol. 658, p. 276-285
Keywords [en]
CDT; Iron-based borides; Boron cluster; Melanoma
National Category
Organic Chemistry
Identifiers
URN: urn:nbn:se:liu:diva-200229DOI: 10.1016/j.jcis.2023.12.078ISI: 001138931500001PubMedID: 38104410OAI: oai:DiVA.org:liu-200229DiVA, id: diva2:1829155
Note
Funding Agencies|National Natural Science Foundation [22179100]; Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University [ZNQNJC2023009]; Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province [CXPJJH122006-1014]; Hubei Provincial Natural Science Foundation [2022CFB616]; Fundamental Research Funds for the Central Universities [413000404]; Olle Engkvist Byggmastare foundation [212-0178]; Swedish Research Council [2018-05973]
2024-01-182024-01-182024-01-18